Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Focused Workshops at RESI Partnering Week

2 Sep

By Gregory Mannix, Vice President International Business Development, General Manager Europe, LSN

RESI Partnering Week (RPW) – September 13-17, 2021 – is much more than an opportunity to meet one-on-one with investors and other key players in the life science space. The conferences also offer quality, live-streaming workshops on an array of hot topics that are particularly relevant to the space, sponsored by our many great partners. The live format allows for interactive Q&A and makes the sessions more dynamic.

Here are some examples of great content you can expect at RPW:

September 13, 5 PM EDT | Digital RESI September

Why US Biotechs are Coming to Australia and How They are Saving in Regulatory Timelines and Considerable Costs
Yvonne Lungershausen, CEO, Avance Clinical

Learn how U.S. biotechs expedite their early phase clinical research program. With no IND required to start your clinical program in Australia, biotechs are able to save up to a year in regulatory timelines and considerable costs.

September 14, 9 AM EDT | Digital RESI September

Company Valuation for Fundraising – Trends and Tools
Patrik Frei, Founder & CEO, Venture Valuation AG, Switzerland
Gergely Ivanyi, PharmD, Business Analyst, Venture Valuation

Valuation is a key aspect of fundraising. An average value assumption for each company in a specific financing stage just does not do it anymore. For entrepreneurs, as for investors, it’s important to understand the value drivers of a company. We are looking at the financing trends of the last years, discuss dos and don’ts when speaking with investors and look at how to value a life science company with no revenues.

September 14, 3PM EDT | Digital RESI September | RESI AI (Pre-Recorded) | RESI Longevity (Pre-Recorded)

Fundraising Bootcamp
Dennis Ford, CEO, Life Science Nation

The Fundraising Boot Camp provides a top-to-bottom master class on outbound global fundraising. Topics to be covered include the Changing Investor Landscape, New Categories of Life Science Investors, Debunking the Top 10 Old Myths in Fundraising, Planning & Infrastructure for an Outbound Fundraising Campaign, Building Your Brand Through Consistent Messaging and Key Components of Fundraising Marketing Collateral. It will bring you step-by-step through the processes of positioning, marketing collateral, website creation, branding & messaging, and how to reach out to a list of global investors.

September 15, 11 AM EDT | Digital RESI September

Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Instructor to be Announced, McDermott Will & Emery

This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion.

September 15, 1 PM EDT | Digital RESI September

Financing Scientific Instrumentation as a Startup Company
Darren Platt, President, Demetrix
Bryan Leavitt, Managing Partner, Fountainhead Investment Partner
Chad Kobold, Director of Business, Development, Bold View Capital

Over the last several years, a record number of exciting life sciences start-ups have come online. Most of these start-up companies need scientific instrumentation to support their research. But when funds are limited, how can these companies get the instrumentation needed to hit their growth milestones? Workshop will kick off with an overview of the leasing market for start-ups. Expert panel will share their own experiences going through the leasing process and offer valuable lessons learned. 

September 17, 11 AM EDT | RESI AI

How to Go to Market: Commercializing AI-Based Health Technologies
Richie Bavasso, MBA, Co-Founder & CEO, nQ Medical Inc.
Carolyn Metnick, JD, Partner, McDermott Will & Emery
Fahad Rahman, MBA, Co-Founder & CEO, Lumi Health
Michael Ryan, JD, Partner, McDermott Will & Emery
Dale Van Demark, JD, Partner, McDermott Will & Emery

This workshop, hosted by our Title Sponsor McDermott Will & Emery, will focus on the various options for and the legal considerations involved with commercializing AI-based healthcare technologies, including regulatory and data strategies. Learn about the range of options, from R&D use to consumer products, from leading members of McDermott’s digital health practice and companies that have blazed the trail.

Sign up to participate at RESI Partnering Week, September 13-17, and learn more about sponsoring workshops at future events!

490

Artificial Intelligence for Quality Management in Radiology

30 Aug

Aviel Blumenfeld

 Interview with Aviel Blumenfeld, CEO & Co-Founder of IMedis

 

By Erika Wu, Business Development Representative, LSN

Aviel Blumenfeld is the CEO & Co-Founder of IMedis, an Israeli-based company that is creating a comprehensive quality management platform for radiology departments using ground-breaking AI technology to improve clinical outcomes, reduce risks of wrong diagnosis, and increase efficiency. IMedis’ solution uses a unique combination of image analysis and text analysis using AI for the detection and surfacing of various failure points throughout the radiology workflow. In addition, IMedis has a strong and cohesive team and is backed by a leading digital health VC. With a growing pipeline of collaborations in pilots, the company is exactly at the deflection point for using digital health for promoting quality-based healthcare. Aviel has worked in the medical devices field for 15 years in various positions including clinical applications specialists, software engineer, algorithm engineer, product manager and VP of R&D. At IMedis, Aviel handles management, strategy, operation, business development and fundraising. 

Erika Wu (EW): IMedis pitched at the Innovator’s Pitch Challenge at RESI AI, January 2021 and Digital RESI, March 2021. What are you currently doing to grow IMedis and where is the company right now?

Aviel Blumenfeld (AB): IMedis is focusing on its go-to-market strategy and has already had several first early adopters in the US and UK starting to use Duali-Q for surfacing actionable missed findings in radiology reports. We expect to receive our first FDA clearance for our clinical offering by early 2022 and to start accelerating our commercial activity and growth of the company. Later this year we are planning to have our Series A-round in order to support the early stage of commercialization of the company, expedite development of new solutions and regulatory approvals.

EW: How would you describe AI?

AB: Professionals’ best assistance.

EW: As many were in your shoes at one point, what are some challenges you’ve learned from? Can you provide any advice, and how has your findings impacted your plan moving forward?

AB: In every conversation, you can learn something new, so keep close relationships with your potential customers, users and partners to better understand their needs and motivation. Early stages of a startup company are very fragile. When the pandemic started we were afraid that we would completely lose the attention of our target customers in the US while they were focused on treating COVID patients and significantly reducing their capacity of radiological examinations. We adopted our go-to-market strategy quickly and approached a new geographical market in the UK as we recognized the NHS which strengthened its digital adoption and openness to new technologies. The benefits of our solution are, first of all, for the patients with improved health outcomes, but also for large health systems by promoting early detection of life-threatening diseases — this is why we see a great potential in the UK as well as with large health systems in the US. We are aiming to keep developing our platform to cover more and more potential failure points and to offer the first in kind comprehensive solution for quality assurance in radiology.

Learn more about IMedis and connect with AI investors at Digital RESI AI (September 16-17)! 

490

Free Fundraising Bootcamp Today!

26 Aug

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

All Life Science Nation (LSN)’s services are dedicated to facilitating connections between early-stage life science companies and investors/strategic partners. To advance the mission of connecting companies and capital, as well as help more life science entrepreneurs prepare for global fundraising, we have organized and hosted several free Fundraising Bootcamps this summer.

sign-up-for-free
These free Fundraising Bootamps are not only great sessions to familiarize oneself with LSN’s services that can be leveraged for fundraising efforts, such as the LSN Investor Database or RESI Partnering Week, September 13-17, but they also provide fundamental insights regarding the fundraising process, covering topics including:

  • Top 10 Common Myths in Fundraising
  • How to Prepare Your Messaging for Investor Outreach
  • How to Prepare for Meetings

Sign up for today’s free Fundraising Bootcamp at 2 PM EDT!

The Reglagene Story and How They Learned to Tell It

26 Aug

By Rory McCann, Marketing Manager & Conference Producer, LSN

Like most scientist-entrepreneurs, Reglagene CEO, Richard Austin thought the compelling story of his company and their precision chemotherapy technology would be enough to get the attention of investors. He quickly learned the importance of marketing the company and telling their story was also integral to their growth. His early experiences with RESI served as classroom, arena, and runway to success.

In our interview, Richard references the education he received from Life Science Nation CEO, Dennis Ford. Dennis is hosting the Global Roadshow Prep Course: a hands-on, comprehensive, one-day course designed to set up the early-stage life science executive for success as they conduct their global fundraise. Each class is open to 24 early-stage, fundraising entrepreneurs and includes premier access to RESI Partnering Week, September 13-17.

The Global Roadshow Prep Course takes place Friday, September 3 and September 10. View the agenda and sign up to jumpstart your fundraising through telling your story and connecting with the right investors for you!

Saving Critical Time for Blood Cancer Detection & Decisions with AI Interview with Andrea Wang, MS, CEO & Co-Founder, AHEAD Medicine

24 Aug

By Erika Wu, Business Development Representative, LSN

Launching recent partnerships with Mayo Clinic and Roswell Park Comprehensive Cancer Center, Andrea Wang and her team at AHEAD Medicine is paving the way for blood cancer detection and clinical decisions using AI-powered analytics.

As a 9-time RESI attendee, panelist, and Innovator Pitch Challenge (IPC) participant, we are excited to see where AHEAD is going next. Get in front of AI investors at Digital RESI AI (September 16-17) by pitching your company at  Innovator’s Pitch Challenge!

Deadline is Tomorrow – Gain More Exposure at RESI Partnering Week’s Innovator’s Pitch Challenge

19 Aug

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Life Science Nation’s next RESI Partnering Week is coming up in less than a month, which means an intensive week of 1-on-1 virtual partnering meetings, panels, workshops, and of course, the Innovator’s Pitch Challenge(IPC), all taking place September 13-17.

Since last year’s introduction to the IPC, its popularity has skyrocketed and is now one of the most anticipated sections of the Digital RESI Partnering Week menu. With its unique format, selected IPC participants can showcase their technology through a dedicated landing page, which will include a pre-recorded pitch video. Each company will participate in a live Q&A session, joined by a panel of investors and industry experts who will have reviewed the pitch video beforehand.

Below are the companies who have been selected for the upcoming IPC so far across all 3 conferences of RESI Partnering Week – Digital RESI, RESI AI, and RESI Longevity.

Whether you are part of a startup looking to boost exposure or an investor seeking novel innovations that fit your interests, you do not want to miss out on the upcoming RESI Partnering Week. Register and apply now! Applications must be in by Friday, August 20.

Partnering Opens Next Week

19 Aug

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Partnering for RESI Partnering Week, taking place September 13-17, launches Monday, giving companies a chance to connect with investors. The LSN Partnering Platform offers startups an unprecedented opportunity to search for and identify investors that are a fit for them based on sector, stage of development and other helpful criteria. Successful partnering takes a lot of work, and the companies that book the most meetings send, on average, over 100 meeting requests to relevant investors, followed by frequent follow-ups. We will be offering free partnering tutorials for registered attendees in the weeks before the conference takes place. Take a look at the registered investors below, and make sure to register now before partnering launches!

Confirmed RESI Partnering Week Investors

← Older Entries
Newer Entries →